Article

(2019) TBX18 transcription factor overexpression in human-induced pluripotent stem cells increases their differentiation into pacemaker-like cells. Journal of Cellular Physiology. pp. 1534-1546. ISSN 0021-9541

(2018) Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up. Cytotherapy. pp. 660-669. ISSN 1465-3249

(2018) COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133(+) Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial. Cell Journal. pp. 267-277. ISSN 2228-5806

(2018) Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. pp. 499-506. ISSN 1465-3249

(2017) Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Research & Therapy. p. 11. ISSN 1757-6512

(2013) PHASE III RANDOMIZED CLINICAL TRIAL COMPARING THE EFFECTS OF AUTOLOGOUS BONE MARROW DERIVED MNC AND CD133 CELLS TRANSPLANTATION IN AMI PATIENTS DURING CABG. Cytotherapy. S12-S12. ISSN 1465-3249

(2012) Five-Year Follow-up of the Local Autologous Transplantation of CD133+Enriched Bone Marrow Cells in Patients with Myocardial Infarction. Archives of Iranian Medicine. pp. 32-35. ISSN 1029-2977